CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −630 | $547.47 | $345K | 325,883 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −698 | $548.49 | $383K | 325,185 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −502 | $549.47 | $276K | 324,683 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $550.59 | $88K | 324,523 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $551.49 | $44K | 324,443 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 242,910 | ||
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −428 | $548.13 | $235K | 333,515 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,329 | $549.01 | $730K | 332,186 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,565 | $550.03 | $1.4M | 329,621 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,628 | $551.10 | $1.4M | 326,993 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,857 | $551.92 | $1.0M | 325,136 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −558 | $552.93 | $309K | 324,578 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −135 | $554.46 | $75K | 324,443 |
| 2026-10-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 252,410 | ||
| 2026-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $531.92 | $64K | 333,823 |
| 2026-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $533.80 | $171K | 333,503 |
| 2026-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $534.80 | $342K | 332,863 |
| 2026-10-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $536.09 | $214K | 332,463 |
Page 20 of 120 · 2,391 trades